Heterozygous alpha-1-antitrypsin deficiency (PiMZ): Risk factor in the development of primary liver carcinoma in non-cirrhotic liver?;Heterozygoter Alpha-1-Antitrypsin-Mangel (PiMZ): Risikofaktor zur Entwicklung eines hepatozellulären Karzinoms in der nicht zirrhotischen Leber?

Zeitschrift fur Gastroenterologie

Volumn 48, Issue 10, 2010, Pages 1211-1214

  Manekeller, S ^a   Sauerbruch, T ^a   Fischer, H P ^a   Propping, P ^a   Hirner, A ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Alpha 1 Antitrypsin deficiency; endoplasmic reticulum; hepatocarcinogenesis

Indexed keywords

AGED; ALCOHOLISM; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE REPORT; CODON; COMORBIDITY; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG EMPHYSEMA;

AGED; ALPHA 1-ANTITRYPSIN; CARCINOMA, HEPATOCELLULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 77957563672     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1245204     Document Type: Article

References (24)

1. Silverman E K., Sandhaus R A. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med 2009 360 2749-2757
2. Norman M R., Mowat A P., Hutchinson D CS. Molecular basis, clinical consequences and diagnosis of alpha-1-antitrypsin deficiency. Ann Clin Biochem 1997 34 230-246
3. Zhou H, Fischer H P. Liver morphology in heterozygous alpha-1-antitrypsin deficiency PiZ. Pathologe 2000 21 433-440
4. Eriksson S. Liver disease and intermediate alpha-1-antitrypsin deficiency. Acta Med Scand 1981 210 241-244
5. Perlmutter D H. Alpha-1-antitrypsin deficiency. Sem Liv Dis 1998 18 217-225
6. Needham M, Stockley R A. 1-Antitrypsin deficiency 3: Clinical manifestations and natural history. Thorax 2004 59 441-445
7. Sveger T. The natural history of liver disease in alpha-1-antitrypsin deficient children. Acta Paediatr Scand 1995 77 847-851
8. Brantly M L., Paul L D., Miller B H. et al. Clinical features and natural history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988 138 327-336
9. Chappell S, Hadzic N, Stockley R et al. A polymorphism of the alpha1-antitrypsin gene represent a risk factor for liver disease. Hepatology 2008 47 127-132
10. Perlmutter D H. Liver injury in 1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest 2002 110 1579-1583
11. Lomas D A., Mahadeva R. 1-Antitrypsin polymerization and the serinopathies: pathobiology and prospects for therapy. J Clin Invest 2002 110 1585-1590
12. Elliot P R., Lomas D A., Carrell R W. et al. Inhibitory conformation of the reactive loop of 1-antitrypsin. Nat Struct Biol 1996 3 676-681
13. Rudnick D A., Perlmutter D H. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 2005 42 514-521
14. Teckman J H., Burrows J, Hidvegi T et al. The proteasome participants in degradation of mutant 1-Antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem 2001 276 44 865-44 872
15. Perlmutter D H. Autophagic disposal of the aggregation-prone protein that cause liver inflammation and carcinogenesis in 1-Antitrypsin deficiency. Cell Death and Differ 2009 16 39-45
16. Perlmutter D H. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res 2006 60 233-238
17. Lindblad D, Blomenkamp K, Teckman J. Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model. Hepatology 2007 46 1228-1235
18. Zhou H, Ortiz-Pallardo M E., Ko Y et al. Is heterozygot alpha-1-antitrypsin deficiency type PiZ a risk factor for primary liver carcinoma? Cancer 2000 88 2668-2676
19. Rabinovitz M, Gavaler J S., Kelly R H. et al. Lack of increase in heterocygous 1-Antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma. Hepatology 1992 15 407-410
20. Kok K F., Wahab R HJ, Drenth J PH et al. Heterozygous alpha-1-antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review. Neth J Med 2007 65 160-166
21. Piitulainen E, Carlson J, Ohlson K et al. Alpha-1-antitrypsin deficiency in 26-year-old subjects : lung, liver, and protease/protease inhibitor studies. Chest 2005 128 2076-2081
22. Fairbanks K D., Tavill A S. Liver disease in alpha-1-antitrypsin deficiency: a review. Am J Gastroenterol 2008 103 2136-2141
23. Qu D, Teckman J H., Perlmutter D H. Review: alpha-1-deficiency associated liver disease. J Gastroenterol Hepatol 1997 12 404-416
24. Fregonese L., Stolk J., Hereditary alpha-1-antitrypsin deficiency and its clinical consequences, Orphanet J Rare Dis 2008 19 3-16.